Rhumbline Advisers Has $43.09 Million Position in Waters Co. (NYSE:WAT)

Rhumbline Advisers trimmed its holdings in Waters Co. (NYSE:WAT) by 2.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 116,153 shares of the medical instruments supplier’s stock after selling 3,416 shares during the quarter. Rhumbline Advisers owned about 0.20% of Waters worth $43,090,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in WAT. Advisory Alpha LLC lifted its stake in Waters by 2.6% in the fourth quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier’s stock valued at $395,000 after buying an additional 27 shares during the period. Summit Trail Advisors LLC lifted its position in shares of Waters by 2.4% during the 3rd quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier’s stock valued at $431,000 after acquiring an additional 28 shares during the period. Empowered Funds LLC boosted its stake in Waters by 3.0% during the fourth quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier’s stock worth $358,000 after acquiring an additional 28 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. grew its holdings in Waters by 0.3% in the fourth quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier’s stock worth $3,565,000 after purchasing an additional 30 shares during the period. Finally, OneDigital Investment Advisors LLC increased its stake in Waters by 3.8% in the third quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 31 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

WAT has been the subject of several research reports. StockNews.com upgraded Waters from a “hold” rating to a “buy” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft boosted their price objective on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a report on Monday, November 4th. Sanford C. Bernstein upgraded Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price on the stock in a report on Friday, January 10th. Stifel Nicolaus boosted their price target on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Barclays raised shares of Waters from an “underweight” rating to an “equal weight” rating and raised their price objective for the company from $360.00 to $415.00 in a research note on Monday, February 10th. Ten research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $390.40.

Waters Stock Performance

Shares of WAT opened at $369.71 on Tuesday. Waters Co. has a 1 year low of $279.24 and a 1 year high of $423.56. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38. The stock’s fifty day moving average price is $389.40 and its two-hundred day moving average price is $364.87. The firm has a market cap of $21.95 billion, a PE ratio of 35.28, a PEG ratio of 7.37 and a beta of 1.01.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.43% and a return on equity of 49.93%. On average, equities research analysts forecast that Waters Co. will post 11.79 EPS for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.